Tags

Type your tag names separated by a space and hit enter

Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
Prostate Cancer Prostatic Dis 2008; 11(3):247-51PC

Abstract

We hypothesized that prostate cancer screening and availability of urologists among states may be associated with reduced prostate cancer mortality in the United States. To test this hypothesis, state-specific prostate cancer mortality rates for white males were compared to urologist population densities and prostate-specific antigen (PSA) screening rates on a state-by-state basis. The urologist population density was calculated by dividing the number of urologists per state by the population. We found that prostate cancer mortality rates correlated inversely with urologist population densities (P<0.01) and PSA screening (P<0.01) suggesting that screening and treatment reduce prostate cancer mortality.

Authors+Show Affiliations

Department of Urology, University of Alabama, Birmingham, AL 35294, USA. jan.colli@ccc.uab.eduNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

18268527

Citation

Colli, J L., and C L. Amling. "Prostate Cancer Mortality Rates Compared to Urologist Population Densities and Prostate-specific Antigen Screening Levels On a State-by-state Basis in the United States of America." Prostate Cancer and Prostatic Diseases, vol. 11, no. 3, 2008, pp. 247-51.
Colli JL, Amling CL. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America. Prostate Cancer Prostatic Dis. 2008;11(3):247-51.
Colli, J. L., & Amling, C. L. (2008). Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America. Prostate Cancer and Prostatic Diseases, 11(3), pp. 247-51. doi:10.1038/pcan.2008.7.
Colli JL, Amling CL. Prostate Cancer Mortality Rates Compared to Urologist Population Densities and Prostate-specific Antigen Screening Levels On a State-by-state Basis in the United States of America. Prostate Cancer Prostatic Dis. 2008;11(3):247-51. PubMed PMID: 18268527.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America. AU - Colli,J L, AU - Amling,C L, Y1 - 2008/02/12/ PY - 2008/2/13/pubmed PY - 2008/11/19/medline PY - 2008/2/13/entrez SP - 247 EP - 51 JF - Prostate cancer and prostatic diseases JO - Prostate Cancer Prostatic Dis. VL - 11 IS - 3 N2 - We hypothesized that prostate cancer screening and availability of urologists among states may be associated with reduced prostate cancer mortality in the United States. To test this hypothesis, state-specific prostate cancer mortality rates for white males were compared to urologist population densities and prostate-specific antigen (PSA) screening rates on a state-by-state basis. The urologist population density was calculated by dividing the number of urologists per state by the population. We found that prostate cancer mortality rates correlated inversely with urologist population densities (P<0.01) and PSA screening (P<0.01) suggesting that screening and treatment reduce prostate cancer mortality. SN - 1476-5608 UR - https://www.unboundmedicine.com/medline/citation/18268527/Prostate_cancer_mortality_rates_compared_to_urologist_population_densities_and_prostate_specific_antigen_screening_levels_on_a_state_by_state_basis_in_the_United_States_of_America_ L2 - http://dx.doi.org/10.1038/pcan.2008.7 DB - PRIME DP - Unbound Medicine ER -